Evidence map›Paper›PMID 30444868›Full record

ArticlePloS one2018

Exploring patient information needs in type 2 diabetes: A cross sectional study of questions.

Colleen E Crangle, Colin Bradley, Paul F Carlin, Robert J Esterhay, Roy Harper, Patricia M Kearney, Vera J C McCarthy, Michael F McTear, Eileen Savage, Mark S Tuttle and 1 more

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Observational
  2. Article
  3. Pathway From Type 2 Diabetes Diagnosis to Action: How to Move People Forward.Diabetes spectrum : a publication of the American Diabetes Association · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Colleen E CrangleDepartment of Health Management and Systems Sciences, School of Public Health and Information Sciences, University of Louisville, Louisville, Kentucky, United States of America.ORCID 0000-0001-5840-855X
Colin BradleyDepartment of General Practice, University College Cork, Cork, Ireland.
Paul F CarlinSouth Eastern Health and Social Care Trust, Research Office, Dundonald, Northern Ireland, United Kingdom.
Robert J EsterhayDepartment of Health Management and Systems Sciences, School of Public Health and Information Sciences, University of Louisville, Louisville, Kentucky, United States of America.
Roy HarperDepartment of Endocrinology & Diabetes, The Ulster Hospital, South Eastern Health and Social Care Trust, Dundonald, Northern Ireland, United Kingdom.
Patricia M KearneyDepartment of Epidemiology & Public Health, University College Cork, Cork, Ireland.
Vera J C McCarthySchool of Nursing and Midwifery, University College Cork, Cork, Ireland.
Michael F McTearSchool of Computing and Mathematics, University of Ulster at Jordanstown, Jordanstown, Northern Ireland, United Kingdom.
Eileen SavageSchool of Nursing and Midwifery, University College Cork, Cork, Ireland.
Mark S TuttleBoard of Directors, Apelon Inc., Hartford, Connecticut, United States of America.
Jonathan G WallaceSchool of Computing and Mathematics, University of Ulster at Jordanstown, Jordanstown, Northern Ireland, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study set out to analyze questions about type 2 diabetes mellitus (T2DM) from patients and the public. The aim was to better understand people's information needs by starting with what they do not know, discovered through their own questions, rather than starting with what we know about T2DM and subsequently finding ways to communicate that information to people affected by or at risk of the disease. One hundred and sixty-four questions were collected from 120 patients attending outpatient diabetes clinics and 300 questions from 100 members of the public through the Amazon Mechanical Turk crowdsourcing platform. Twenty-three general and diabetes-specific topics and five phases of disease progression were identified; these were used to manually categorize the questions. Analyses were performed to determine which topics, if any, were significant predictors of a question's being asked by a patient or the public, and similarly for questions from a woman or a man. Further analysis identified the individual topics that were assigned significantly more often to the crowdsourced or clinic questions. These were Causes (CI: [-0.07, -0.03], p < .001), Risk Factors ([-0.08, -0.03], p < .001), Prevention ([-0.06, -0.02], p < .001), Diagnosis ([-0.05, -0.02], p < .001), and Distribution of a Disease in a Population ([-0.05,-0.01], p = .0016) for the crowdsourced questions and Treatment ([0.03, 0.01], p = .0019), Disease Complications ([0.02, 0.07], p < .001), and Psychosocial ([0.05, 0.1], p < .001) for the clinic questions. No highly significant gender-specific topics emerged in our study, but questions about Weight were more likely to come from women and Psychosocial questions from men. There were significantly more crowdsourced questions about the time Prior to any Diagnosis ([(-0.11, -0.04], p = .0013) and significantly more clinic questions about Health Maintenance and Prevention after diagnosis ([0.07. 0.17], p < .001). A descriptive analysis pointed to the value provided by the specificity of questions, their potential to disclose emotions behind questions, and the as-yet unrecognized information needs they can reveal. Large-scale collection of questions from patients across the spectrum of T2DM progression and from the public-a significant percentage of whom are likely to be as yet undiagnosed-is expected to yield further valuable insights.

Indexed as

Diabetes Mellitus, Type 2Patient Education as TopicSex CharacteristicsSurveys and QuestionnairesCross-Sectional StudiesFemaleHumansMaleRisk Factors

Identifiers

PMID30444868
PMCPMC6239280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.